Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQE Regulatory News (IQE)

Share Price Information for IQE (IQE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 28.90
Bid: 28.40
Ask: 28.80
Change: 0.90 (3.21%)
Spread: 0.40 (1.408%)
Open: 30.00
High: 30.00
Low: 28.35
Prev. Close: 28.00
IQE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

IQE plc: Total voting rights and Block Admission Return

4 Jan 2022 10:30

IQE plc: Total voting rights and Block Admission Return

IQE plc

Total Voting Rights and Block Admission Return

Cardiff, UK4 January 2022

(“IQE” or the “Company”)

Total Voting Rights

As at 31 December 2021, the Company’s issued share capital consisted of 803,559,871 ordinary shares of 1 pence each (“Ordinary Shares”). All of these Ordinary Shares carry voting rights of one vote per Ordinary Share. The Company holds 4,115 Ordinary Shares in treasury.

The total number of voting rights in the Company is therefore 803,555,756. Shareholders may use this figure as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the Financial Conduct Authority's Disclosure Guidance and Transparency Rules.

Block Admission Return

The Company hereby provides an update to its block admission filed on 30 June 2021.

Name of company:IQE plc
  
Name of scheme:All employee share option plan
  
Period of return:1 July 2021 to 31 December 2021
  
Number of Ordinary Shares not issued under scheme at the end of the last period:8,954,478
  
Number of Ordinary Shares issued under scheme during period:1,549,277
  
Number of Ordinary Shares cancelled under the scheme during period:Nil
  
Number of Ordinary Shares added to the scheme during period:0
  
Balance of Ordinary Shares under scheme not yet issued at end of period:7,405,201
Number and class of Ordinary Shares originally admitted under scheme and the date of admission:1,000,000 Ordinary Shares (4 Dec 2009)2,000,000 Ordinary Shares (11 Oct 2010)5,000,000 Ordinary Shares (8 Nov 2010)8,000,000 Ordinary Shares (5 Apr 2011)6,000,000 Ordinary Shares (16 May 2012)16,000,000 Ordinary shares (19 Jun 2012)8,000,000 Ordinary shares (12 Aug 2014)8,000,000 Ordinary shares (3 Dec 2015)12,000,000 Ordinary shares (20 April 2017)14,000,000 Ordinary shares (12 June 2018)12,000,000 Ordinary shares (25 January 2019)3,000,000 Ordinary shares (25 January 2020)8,000,000 Ordinary shares (4 May 2021)

Contacts:

IQE plc+44 (0) 29 2083 9400Phil SmithTim PullenAmy Barlow Peel Hunt LLP (Nomad and Joint Broker)+44 (0) 20 7418 8900Edward KnightPaul GillamJames Smith Citigroup Global Markets Limited (Joint Broker)+44 (0) 20 7986 4000Christopher WrenPeter Catterall

Headland Consultancy (Financial PR) + 44 (0) 20 38054822Andy Rivett-Carnac: +44 (0) 7968 997 365Chloe Francklin: +44 (0)78 3497 4624

ABOUT IQE

http://iqep.com

IQE is the leading global supplier of advanced compound semiconductor wafers and materials solutions that enable a diverse range of applications across:

handset devicesglobal telecoms infrastructureconnected devices3D sensing

As a scaled global epitaxy wafer manufacturer, IQE is uniquely positioned in this market which has high barriers to entry. IQE supplies the whole market and is agnostic to the winners and losers at chip and OEM level. By leveraging the Group’s intellectual property portfolio including know-how and patents, it produces epitaxy wafers of superior quality, yield and unit economics.

IQE is headquartered in Cardiff UK, with c. 670 employees across nine manufacturing locations in the UK, US, Taiwan and Singapore, and is listed on the AIM Stock Exchange in London.

Date   Source Headline
8th Jan 20138:39 amRNSStatement regarding press articles
31st Jul 20123:54 pmRNSDirectorate Change
10th Apr 20125:11 pmRNSDirector Dealings
27th Mar 20122:00 pmRNSPartnership Agreement
8th Feb 20124:10 pmRNSCompletion of Placing
17th Feb 20103:56 pmRNSNominated Adviser Change of Name
7th Aug 20094:42 pmRNSHolding(s) in Company
7th Aug 20094:30 pmRNSBondholders meeting
7th Aug 20093:51 pmRNSDirector Dealing in Shares
12th Jun 20081:42 pmRNSAdditional Listing
15th Apr 20087:01 amRNSAdditional Listing
7th Apr 200812:14 pmRNSDirector/PDMR Shareholding
28th Mar 200811:52 amRNSDirector/PDMR Shareholding
19th Mar 20087:00 amRNSDirector/PDMR Shareholding
17th Mar 20081:00 pmRNSContract Win
17th Mar 20087:01 amRNSFinal Results
28th Feb 20083:27 pmRNSHolding(s) in Company
19th Feb 20088:30 amRNSNotice of Results
25th Jan 20087:00 amRNSBank Facilities
17th Jan 20087:00 amRNSTrading Update
16th Jan 200811:15 amRNSBroker Appointment
15th Jan 200812:12 pmRNSDirector/PDMR Shareholding
9th Jan 20084:26 pmRNSAdditional Listing
7th Jan 20087:00 amRNSDirector/PDMR Shareholding
4th Jan 200812:46 pmRNSHolding(s) in Company
19th Dec 20077:30 amRNSAdditional Listing
18th Dec 20073:52 pmRNSSubstrate supply contract
13th Dec 20077:01 amRNSSuccessful Qualifications
9th Nov 200710:53 amRNSDirector/PDMR Shareholding
3rd Oct 200710:41 amRNSDirector/PDMR Shareholding
1st Oct 20072:44 pmRNSAdditional Listing
28th Sep 200710:14 amRNSContract Win
28th Sep 20078:12 amRNSInvestor Presentation
4th Sep 200712:03 pmRNSDirector/PDMR Shareholding
28th Aug 20072:17 pmRNSHolding(s) in Company
24th Aug 20073:36 pmRNSHolding(s) in Company
22nd Aug 20077:01 amRNSContract Win
22nd Aug 20077:01 amRNSInterim Results
15th Aug 20077:01 amRNSIFRS Transitional Stmnt - Amd
14th Aug 20077:01 amRNSIFRS Transitional Statement
13th Aug 20071:19 pmRNSRule 26 Compliance
2nd Aug 20078:39 amRNSResearch Consortium
1st Aug 20073:52 pmRNSNotice of Results
25th Jul 20071:35 pmRNSResult of AGM
11th Jul 20078:00 amRNSHolding(s) in Company
9th Jul 20077:00 amRNSTrading Statement
18th Jun 20073:35 pmRNSHolding(s) in Company
4th Jun 20074:15 pmRNSHolding(s) in Company
29th May 20074:48 pmRNSAdditional Listing
24th Apr 20071:58 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.